EDGAR Filing Documents for 0001171843-15-003968

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001171843-15-003968

Filing Date

2015-07-22

Accepted

2015-07-22 16:58:59

Documents

Period of Report

2015-07-20

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	gff4_072215knapp.html	4
1	OWNERSHIP DOCUMENT	gff4_072215knapp.xml	4	17620
	Complete submission text file	0001171843-15-003968.txt		19245

Mailing Address 4640 SW MACADAM AVE., SUITE 270 PORTLAND OR 97239

Business Address

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 151000480

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400

Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations